Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys.
Zamora V, Garin O, Pardo Y, Pont À, Gutiérrez C, Cabrera P, Gómez-Veiga F, Pijoan JI, Litwin MS, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Zamora V, et al. Value Health. 2021 Nov;24(11):1676-1685. doi: 10.1016/j.jval.2021.03.021. Epub 2021 Sep 8. Value Health. 2021. PMID: 34711369 Free article.
Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres.
Lopes de Castro C, Fundowicz M, Roselló A, Jové J, Deantonio L, Aguiar A, Pisani C, Villà S, Boladeras A, Konstanty E, Kruszyna-Mochalska M, Milecki P, Jurado-Bruggeman D, Lencart J, Modolell I, Muñoz-Montplet C, Aliste L, Torras MG, Puigdemont M, Carvalho L, Krengli M, Guedea F, Malicki J. Lopes de Castro C, et al. Among authors: jove j. Sci Rep. 2021 Jun 10;11(1):12323. doi: 10.1038/s41598-021-91723-0. Sci Rep. 2021. PMID: 34112863 Free PMC article.
Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice.
Torras MG, Canals E, Jurado-Bruggeman D, Marín-Borras S, Macià M, Jové J, Boladeras AM, Muñoz-Montplet C, Molero J, Picón C, Puigdemont M, Aliste L, Torrents A, Guedea F, Borras JM. Torras MG, et al. Among authors: jove j. Transl Oncol. 2018 Jun;11(3):794-799. doi: 10.1016/j.tranon.2018.03.015. Epub 2018 Apr 26. Transl Oncol. 2018. PMID: 29704788 Free PMC article.
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Bonet M, González D, Baquedano JE, García E, Altabas M, Casas F, Feltes N, Ferrer F, Foro P, Fuentes R, Galdeano M, Gomez D, Henriquez I, Jové J, Lozano J, Maldonado X, Mases J, Membrive I, Paredes S, Roselló À, Sancho G, Mira M. Bonet M, et al. Among authors: jove j. Clin Transl Oncol. 2023 Apr;25(4):1017-1023. doi: 10.1007/s12094-022-03005-4. Epub 2022 Nov 27. Clin Transl Oncol. 2023. PMID: 36436177
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR).
Valero J, Peleteiro P, Henríquez I, Conde A, Piquer T, Lozano A, Soler CC, Muñoz J, Illescas A, Jove J, Flores MM, Baquedano J, Diezhandino P, de Celis RP, Pardo EH, Samper P, Villoslada I, Eguiguren M, Millan V. Valero J, et al. Among authors: jove j. Clin Transl Oncol. 2020 Aug;22(8):1378-1389. doi: 10.1007/s12094-019-02274-w. Epub 2020 Jan 27. Clin Transl Oncol. 2020. PMID: 31989474
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.
Gomez-Iturriaga A, Cabeza Á, Pastor J, Jove J, Casaña M, Caamaño AG, Mengual J, Henríquez I, Muñoz J, Hervás A, Segundo CG. Gomez-Iturriaga A, et al. Among authors: jove j. Clin Transl Oncol. 2016 Oct;18(10):1026-33. doi: 10.1007/s12094-016-1481-5. Epub 2016 Jan 19. Clin Transl Oncol. 2016. PMID: 26781470
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes.
González-San Segundo C, Jové J, Zapatero A, Pastor-Peidro J, Vázquez ML, Casaña M, Mengual JL, Gómez-Caamaño A, Gómez-Iturriaga A, Vallejo C, Henríquez I, Muñoz-García JL, Clemente J, Porras M, Collado E, Ossola G, Villafranca E, Cabeza MA, López-Torrecilla J. González-San Segundo C, et al. Among authors: jove j. Clin Transl Oncol. 2019 Aug;21(8):1044-1051. doi: 10.1007/s12094-018-02021-7. Epub 2019 Jan 7. Clin Transl Oncol. 2019. PMID: 30617939
74 results